Posts Tagged ‘White House’

Health insurance executives and commissioners gathered in the Roosevelt room at the White House with Health and Human Services (HHS) Secretary Kathleen Sebelius March 3 to discuss insurance rate hikes that have occurred or are set to occur across the country.

According to an HHS Assistant Secretary for Public Affairs (ASPA) pool report, the meeting began at 11 a.m. with Sebelius thanking everyone for “being here on short notice to have this conversation.” The conversation was just as short.

Read more »

The Military Health System (MHS) set up a version of its Armed Forces Health Longitudinal Technology Application (AHLTA) electronic health record (EHR) system for use in the White House.

Read more »

Health care providers hemming and hawing over electronic health record (EHR) implementation and the viability of earning financial incentives for “meaningful EHR use” need not worry. The federal government is putting up $1.2 billion to ensure your success. Read more »

A line item in the proposed 2010 federal budget sent to Congress Feb. 27 by the White House asks to “ensure that Medicare makes appropriate payments for imaging services through the use of radiology benefit managers” in order to cut utilization costs. Read the full story on DiagnosticImaging.com.

President Obama signed, March 9, an Executive Order entitled “Removing Barriers to Responsible Scientific Research Involving Human Stem Cells.”

The order grants the Secretary of Health and Human Services (HHS), through the Director of National Institutes of Health (NIH), permission to support and conduct “responsible, scientifically worthy” human stem cell research, including human embryonic stem cell research.

Read more »

At a Dec. 11 news conference, President-elect Barack Obama formally nominated former Senator Tom Daschle to be the next Secretary of the Department of Health and Human Services (HHS). The South Dakota Democrat will also lead a White House health care reform team.

In a Dec. 11 news release, HHS Secretary Mike Leavitt said, “I have high regard for Senator Daschle. His leadership experience, familiarity with Washington, and interest in health care will serve him well as secretary.” Read more »

Should individuals be allowed to sue pharmaceutical manufacturers when adverse reactions not clearly identified on drug labels occur? A recent court case has brought that question up for debate again.

The White House and the FDA general counsel say no. Drug regulators and advocacy group leaders say yes. David G. Savage reports on this Oct. 30 story for the Los Angeles Times.